Introduction {#s0001}
============

It is estimated that more than one million workers worldwide perform welding as a part of their work (Sjogren & Langard, [@CIT0031]), and studies have shown that welders experience an increased risk of respiratory illness (Antonini, [@CIT0002]). Welding fumes consist of a mixture of gas and agglomerated particles (networks of interacting particles) that are built up of primary nanoparticles (Jenkins & Eagar, [@CIT0017]). A correlation between exposure to nanoparticles in urban air and adverse health effects, such as cardiovascular disease and pulmonary diseases such as bronchial asthma, has been suggested (Nawrot et al., [@CIT0026]). The welding particles are small enough to remain airborne and are easily inhaled and deposited within the respiratory tract (Oberdorster et al., [@CIT0027]). The effects of these deposited particles are probably dependent on particle parameters, e.g. chemical composition, size, surface properties, and shape, which influence solubility and the site of particle deposition in the airways (Maynard & Kuempel, [@CIT0022]).

When particles encounter a biological fluid, molecules such as proteins, lipids, and carbohydrates will, in competition with each other, bind to the particle\'s surface leading to the formation of a dynamic particle--biomolecule interaction (Cedervall et al., [@CIT0009]). The protein corona that is formed can have a significant impact on the biological effects of the particles (Saptarshi et al., [@CIT0028]; Tenzer et al., [@CIT0033]). The composition of the protein corona will constantly change until equilibrium is reached (Dell\'orco et al., [@CIT0011]), but some proteins in the corona can remain bound to the particle as it travels from one environment to another (Monopoli et al., [@CIT0023]; Tenzer et al., [@CIT0032]). Most previous investigations of the protein corona of nanoparticles have been performed with blood plasma proteins and only rarely in other fluids (Tenzer et al., [@CIT0033], [@CIT0032]).

Human nasal lavage fluid forms a defense against foreign microbes or particulates being deposited in the nasal cavity (Casado, [@CIT0007]; Casado et al., [@CIT0008]). It contains a variety of proteins from plasma, mucus, serous fluids, and secretions from epithelial and immunological cells (Mygind & Dahl, [@CIT0024]). There is a strong resemblance between the proteins identified in nasal secretions and in bronchoalveolar lavage (Bartlett et al., [@CIT0004]; Benson et al., [@CIT0005]; Kosanam et al., [@CIT0019]) making nasal lavage suitable for investigation of the protein corona formed in the lower airways. Proteomic analysis can provide essential information to help understand the pathophysiologic pathways of the inhaled particles (Casado et al., [@CIT0008]).

In this study, welding fume particles were generated, collected on membranes, extracted, and finally incubated with nasal lavage proteins with the purpose of studying the particle--protein interactions. The aim of the study was to identify the protein corona formed *in vitro* between welding fume particles and nasal lavage proteins and to understand how parameters such as particle size and chemical composition affect the composition and functionality of the protein corona.

Methods {#s0002}
=======

Welding particles {#s0003}
-----------------

### *In situ* characterization of airborne welding particles {#s0004}

The source of the welding fumes was generated by metal active gas welding in mild steel according to the principle developed by Isaxon et al. ([@CIT0016]). The size distribution (mobility diameter) of the agglomerated airborne welding particles (interacting particles built up of primary nanoparticles) was measured using a scanning mobility particle sizer (SMPS, CPC model 3010, TSI Inc., Shoreview, MN). The SMPS covered a size range of 10--700 nm and had a time resolution of ∼3 min. The mass concentration was monitored online using a tapered element oscillating microbalance (Rupprecht & Patashnic Co. Inc., Albany, NY).

### Fractionation and collection of welding particles {#s0005}

Welding particles were collected from a 22 m^3^ stainless steel chamber using a high volume cascade impactor (HVCI; BGI 900 LPM, BGI Incorporated, Waltham, MA). The HVCI had a flow of 0.9 m^3^/min, and particles were collected in fractions of ultrafine welding fume (UF~WF~) particles \< 0.1 μm in diameter and fine welding fume (F~WF~) particles ranging from 0.1 µm to 2.5 μm in diameter. The UF~WF~ fraction was collected on a polytetrafluoroethylene filter (PTFE), and the F~WF~ fraction was collected on polyurethane foam (PUF; Demokritou et al., [@CIT0012]). Welding particles were recovered from the PTFE and PUF using a methanol extraction protocol. The filters were washed repeatedly with methanol, and the resulting solution was decanted into a 50 mL sample tube. The solution was vacuum dried. The extracted particle mass was determined. All weighing was performed in a climate-controlled environment and after a minimum 24-h acclimatization period. The extracted particles were weighed three separate times, and the average mass and the standard deviation were calculated. The chemical composition of the two fractions, F~WF~ and UF~WF~, was analyzed by particle-induced X-ray emission.

Model particles {#s0006}
---------------

Magnetite Fe~3~O~4~ and Fe~2~O~3~ were selected as model particles because iron oxides are the main components of welding fumes. Magnetite Fe~3~O~4~ (8 nm) in 30 wt% aqueous suspension was purchased from PlasmaChem GmbH (Berlin, Germany). Fe~2~O~3~ (20--40 nm, 99% purity) was purchased in the form of dry powder from SkySpring Nanomaterials (Houston, TX).

Particle characterization in fluid {#s0007}
----------------------------------

Each particle type was suspended in 20 mL vials (Scint-Burk glass pp-lock-Alu-foil, Wheaton Industries, Inc., Millville, NJ) to a total concentration of 2.56 mg/mL in milliQ water. The suspension was sonicated for 16 min at 400 W and 10% amplitude using a Vibra-Cell sonifier (Soniucs & Materials, Danbury, CT) according to the Nanogenotox protocol (Jensen, [@CIT0018]). The size of the particles in the suspension was measured by dynamic light scattering (DLS) and nanoparticle tracking analysis (NTA). DLS measurements were performed with a Malvern Zeta NANO S (Malvern Instruments Ltd, Worcestershire, UK) equipped with a 532 nm red laser and operating with a 90 ° scattering angle. The measurements were evaluated with the Zetasizer software version 6.20 (Malvern Instruments Ltd, Worcestershire, UK). All measurements were performed at 25 °C. Each sample was measured at least three times with a delay of 15 s between the measurements, and the stability of the suspension was confirmed by re-measurement after 20 min. The mean hydrodynamic diameter was measured for the agglomerated particles as well as the aggregated form (complexes consisting of several particles each with a protein corona) after incubation with nasal lavage proteins. For some samples, the diameters could be determined by NTA using a NanoSight LM10 (Nanosight Ltd., Amesbury, UK) equipped with a 635 nm laser. All samples were measured at room temperature three times for 60 s.

Transmission electron microscopy (TEM) {#s0008}
--------------------------------------

Particles were collected from the air and from the liquid particle suspensions onto carbon-coated copper grids for TEM analysis. The particles were collected using an electrostatic precipitator (NAS Model 3089, TSI Inc., Shoreview, MN).

Endotoxin quantification {#s0009}
------------------------

To test how much endotoxin the particles contained, a kinetic chromogenic *Limulus Amebocyte Lysate* (LAL) assay (Lonza, Walkersville, MD) was used according to the protocol of the manufacturer. A 7-point standard curve was generated over the concentration range of 0.005--50 endotoxin unit/mL, and a control standard endotoxin *Escherichia coli* O55:B5 was used for reference values. The samples were assayed in a 96-well pyrogen-free microplate (TPP, Hannover, Switzerland), and spectrophotometric measurements were taken at 405 nm.

Collection of nasal lavage {#s0010}
--------------------------

Nasal lavage was collected by flushing the nasal cavity of 20 healthy volunteers with 18 mL of saline solution. The samples were evaporated to dryness, dissolved in 500 µL of milliQ water, pooled, and then desalted in Amicon Ultra-0.5 centrifugal filters (3 kDa cut-off) (Millipore, Carrigtohill, Ireland) at 14 000 × *g* for 30 min. The samples were washed with 300 µL water and centrifuged again for 30 min at 14 000 × *g*. The total protein content was determined with a bicinchoninic acid (BCA) protein assay kit (Pierce, Rockford, IL). The solution of proteins obtained from the pooled nasal lavages was used in all incubations described below.

Particle--nasal lavage protein incubation {#s0011}
-----------------------------------------

For each type of particle suspension, three different amounts of particles were added to a final concentration of 800 μg nasal lavage protein/mL to yield 400, 200, and 100 μg particles/mL, and these were incubated for 6 h at 32 °C ([Scheme 1](#SCH0001){ref-type="scheme"}). All incubations were performed in triplicate. Unbound proteins were separated from the particles by centrifugation for 1 h at 16 000 × *g*. The supernatant was stored for further analysis, and the particle pellet was washed three times with milliQ water followed by a second and third centrifugation. The supernatant was collected and further sampled in triplicate. The amount of bound protein was determined by measuring the amount of proteins that did not bind to the particles using the BCA protein assay kit. Proteins from the different incubations were analyzed by two different methods. Scheme 1.Overview over the experiment. (1) (a) The particles (F~WF~, UF~WF~, Fe~2~O~3~ and Fe~3~O~4~) were suspended in water. (b) Nasal lavage fluids were concentrated and desalted. (2) Each particle type was incubated with nasal lavage proteins for 6 h. (3) Proteins bound to the particles (the protein corona) were separated from unbound proteins by centrifugation. The pellet was either (a) dissolved in water and the proteins were trypsin digested or (b) incubated with denaturing solution. (4) The proteins in the supernatant were trypsin digested. (5) The tryptic peptides from steps 4 and 3b were analyzed with LC-MS/MS. (6) The denatured proteins were separated on 2DE, gel slices were cut out, the proteins were digested with trypsin, and the peptides were identified with MALDI-TOF MS.

Two-dimensional gel electrophoresis (2DE) analysis/matrix-assisted laser desorption/ionization time-of-flight mass spectrometer (MALDI-TOF MS) {#s0012}
----------------------------------------------------------------------------------------------------------------------------------------------

Prior to 2DE analysis, proteins from the coronas formed by the four different particles (three replicates each and a positive control) were suspended in 150 µL of sample buffer containing 9 M urea, 65 mM DTT, 2% Pharmalyte (GE Healthcare, Bioscience, Uppsala, Sweden), 4% CHAPS, and 1% bromophenol blue and then centrifuged at 23 000 × *g* for 30 min at 4 °C. The supernatant containing denatured proteins released from the particles (50 µg protein) was then mixed with a rehydration buffer consisting of 8 M urea, 4% CHAPS, 0.5% immobilized pH gradient, IPG, buffer 3-10NL (GE Healthcare, Bioscience, Uppsala, Sweden), 19 mM DTT, and 5.5 mM Orange G to a final volume of 350 µL. The 2DE was performed in a horizontal 2DE set up IPGphor. The first dimension was performed by in-gel rehydration on pH 3--10 non-linear IPG strips (GE Healthcare, Bioscience, Uppsala, Sweden) and then proteins were transferred to homogenous home-cast gels (0.5 × 180 × 245 mm, 14% T, 1.5% C) running at 20--40 mA, 40--800 V, and 10 °C overnight.

Proteins were silver stained according to Shevchenko ([@CIT0029]) with minor modifications. The protein patterns were then visualized using a cooled charged-coupled device camera digitizing at 1340 × 1040 pixels resolution (Fluor-S Multi-Imager, Bio-Rad, Hercules, CA) in combination with a computerized imaging 12-bit system designed for evaluation of 2DE patterns (PDQuest version 7.1.1, Bio-Rad, Hercules, CA).

The protein spots were excised and destained according to Ghafouri et al. ([@CIT0015]). About 25 µL of 20 µg/mL trypsin in 25 mM ammonium bicarbonate was added to the dried residue, and the samples were incubated overnight at 37 °C. Tryptic peptides were dissolved in trifluoroacetic acid (TFA) and mixed 1:1 with matrix solutions consisting and 1 µL of the solution was spotted on the target plate. Analysis of peptides was performed using MALDI-TOF MS (Voyager-DE PRO, Applied Biosystems, Foster City, CA) equipped with a 337 nm laser and delayed extraction and operated in a reflector mode. Data processing of the spectra was performed with Data Explorer™ (version 4.0, Applied Biosystems, Foster City, CA).

The mass list (mass + H^+^) generated from the 40 most abundant peaks of the MALDI spectra was submitted to a database search (NCBI, or SWISS-PROT, PIR, Newark, DE). Restrictions were placed on species (Human), mass tolerance ( ± 50 ppm), maximum missed cleavages by trypsin (up to 1), and cysteine modification by carbamidomethylation.

Liquid chromatography coupled to mass spectrometry (LC-MS/MS) analysis {#s0013}
----------------------------------------------------------------------

The protein corona samples from four different particles with three different particle concentrations and the supernatant, containing unbound proteins, were reduced by the addition of 2 µL of 50 mM DTT and incubated for 1 h at 60 °C. Proteins were alkylated by the addition of 1 µL of 200 mM iodoacetamide and incubated in darkness at room temperature for 30 min. All experiments were performed in triplicate. To each sample, 10 µL of sequencing-grade trypsin (1:10 trypsin to protein ratio, Roche Diagnostics, Mannheim, Germany) and 1 µL of 100 mM calcium chloride were added. The samples were then incubated overnight at 37 °C. The trypsin-digested samples were centrifuged for 1 h at 16 000 × *g*, and the supernatants containing the trypsin-digested peptides were evaporated to dryness and dissolved in 200 µL milliQ water.

The MS platform was a 5500QTRAP hybrid triple quadropole/linear ion trap mass spectrometer equipped with a TurboIonSpray source (Applied Biosystems, Foster City, CA/MDS Sciex, Framingham, MA) coupled to an online liquid chromatography (LC) system (UFLCXR; Shimadzu Corporation, Kyoto, Japan). A targeted LC-MS/MS method developed specifically for nasal lavage proteins with a total of 245 different proteins was used (Mörtstedt et al., [@CIT0025]). Briefly peptides were separated on a C18-column (2.1 mm × 50 mm, 3 µm pore size, VisionHT C18 CL; Grace Vydac, Hesperia, CA) using 0.1% formic acid in water (A) and 0.1% formic acid in acetonitrile (B) in a gradient from 5% B to 10% B in the first 10 min, from 10% B to 30% B over 15 min, and from 30% B to 99% B over 5 min. Each sample was analyzed twice. Results were integrated in Skyline free software (Skyline, MacCoss Lab at University of Washington, Washington, DC) and manually reviewed. To estimate the degree of binding of each individual protein in the nasal lavage protein solution to the different particle types, a ratio was determined between bound and unbound proteins (*R* ~b/u~), according to the equations below. The mean peak values were calculated for each transition for which the two plus and three plus ions were detected (Equation (1)). Peptide fold changes were calculated by relating the mean peptide peak area from the bound to the mean peptide peak area from the supernatant (Equation (2)). The logarithmic ratio was used from Equation (2) to calculate the median ratio (Bantscheff et al., [@CIT0003]) for each protein, *R* ~b/u~, in Equation (3).

Statistical evaluation {#s0014}
----------------------

All statistical analyses were performed with the SPSS software (SPSS Inc., Chicago, IL). Size differences between F~WF~ and UF~WF~ were statistically evaluated using the Mann--Whitney test. The Jonckheere--Terpstra trend test was used for proteins that showed a decreased *R* ~b/u~ trend with decreasing particle concentrations, and *p* values ≤ 0.05 were considered significant (Bewick et al., [@CIT0006]; Simpson & Margolin, [@CIT0030]). False discovery rate validation of the statistically significant results was pursued with a sequential goodness of fit test using the free software SGoF + (Software AG, Reston, VA) (De Uña-Alvarez & Carvajal-Rodriguez, [@CIT0014]; Diz et al., [@CIT0013]).

Pathway analysis of significantly stable proteins {#s0015}
-------------------------------------------------

Proteins that had high affinity for the particles were further analyzed with Ingenuity Pathways Analysis (IPA) software (Ingenuity Systems, Redwood City, CA, [www.ingenuity.com](http://www.ingenuity.com)) to map interacting networks. Default settings were used except for species, which was set to human, and only experimentally observed relationships were considered.

ELISA (HNE substrate inhibition) {#s0016}
--------------------------------

Detection of secretory leukocyte peptidase inhibitor (SLPI, antileukoproteinase) functionality was performed with a Human Neutrophil Elastase (HNE) Immunocapture Activity Assay Kit (EMD Chemicals, Darmstadt, Germany) that uses a monoclonal antibody to HNE immobilized on a 96-well microplate (EMD Chemicals, Darmstadt, Germany). A total of 100 µL of the 20 ng/mL HNE solution was added to the plates and incubated for 1 h at room temperature. The plate was washed four times with sample buffer followed by addition of SLPI standard, nasal lavage proteins, and different protein coronas for SLPI inhibitor functionality assessment. SLPI standard solutions ranging from 0.01 nM to 7.5 nM along with the SLPI:particle aggregates (diluted to the same SLPI concentrations as for SLPI alone), nasal lavage proteins, particles, nasal lavage protein:particle corona, and a blank with just assay buffer were added in separate wells and incubated for 4 h at 32 °C. SLPI was added to the particles at a concentration similar to the SLPI concentration in nasal lavage, thus 26.4 ng/mL SLPI was incubated with 400 µg/mL particles corona. Material that did not interact with HNE was washed away four times. The activity of HNE was detected with the fluorogenic substrate MeOSuc-Ala-Ala-Pro-Val added to the wells, and the plates were incubated for 4 h at 37 °C. Fluorescence was measured at an excitation wavelength of 370 nm and an emission wavelength of 460 nm and analyzed with a FlexStation 3 Microplate Reader (Molecular Devices, Silicon Valley, CA).

Results {#s0017}
=======

Nanoparticles {#s0018}
-------------

We focused on welding fume particles and two model iron oxide particles, Fe~2~O~3~ and Fe~3~O~4~, which differ in particle size and in oxidation number.

The properties of welding fume particles in air {#s0019}
-----------------------------------------------

The concentration of welding fume particles in the chamber during collection was ∼10^5^/cm^3^. The average number size distribution is shown in [Figure 1](#F0001){ref-type="fig"}. The distribution is, as is typical for distributions of welding fumes in air, lognormal with a geometrical mean diameter of 270 nm. The average mass concentration in the air during collection was, according to the tapered element oscillating microbalance, 2.2 ± 1.2 mg/m^3^. The chemical composition was analyzed and the major constituents of the welding particles after fractionation were iron (75%) and manganese (15%) equally distributed in both F~WF~ and UF~WF~ fractions (Figure S1). Iron was expected to be in the form of the ferrous oxides FeO, Fe~2~O~3~, and Fe~3~O~4~ (Jenkins & Eagar, [@CIT0017]). The welding particles are built up by chain-like structures of a few up to several hundred primary particles ranging in size from 2 nm to 70 nm (Figure S2) (Isaxon et al., [@CIT0016]). Figure 1.Airborne welding fume particles. Log-normal distribution to the average number mobility size distribution of airborne agglomerated welding particles detected with SMPS.

Endotoxin levels in particle suspensions {#s0020}
----------------------------------------

Particles collected from the air can adsorb different compounds. Endotoxins are common in the air, and certain proteins that are present in the airway bind to or have a defense activity against endotoxins. Endotoxin contamination of the particles might influence the pattern of nasal lavage proteins binding to the particles; therefore, the endotoxin levels in the particles were determined. The results showed that the endotoxin levels before incubation in nasal lavage protein solution were low (Table S1). Because the concentrations of endotoxins were three orders of magnitude lower than the particle levels, they were expected to have a minor effect, if any effect at all, on the protein-binding capacity of the particles.

Particle characterization in fluid {#s0021}
----------------------------------

The shape and the number of primary particles in agglomerated particles change when collected from air and suspended in liquid depending on the collection method and the dispersion protocol used. Characterization of the agglomerated particles size after sonication in water was determined by DLS and NTA ([Table 1](#t0001){ref-type="table"} and Figures S3 and S4). Significant differences in mean size (*p* \< 0.01, Mann--Whitney test) between F~WF~ and UF~WF~ were observed, but were not as large as expected. This was likely because large agglomerates can break up and form smaller or new agglomerates after they are suspended in liquid and sonicated. F~WF~ and UF~WF~ have a broad size distribution compared with Fe~2~O~3~ and Fe~3~O~4~ (Figure S3), probably because of the more complex composition of the primary particles both with respect to size and chemical composition. The manufactured Fe~3~O~4~ and Fe~2~O~3~ particles have larger particle diameters than specified by the manufacturer ([Table 1](#t0001){ref-type="table"}), which probably can be explained by the primary particles forming agglomerates. The agglomerated structure was confirmed by TEM (Figures S5 and S6). Table 1.Size increase (mean diameter) between particles suspended in water and following addition of nasal lavage proteins or secretory leukocyte peptidase inhibitor (SLPI).ParticleMean diameter of particles in water ± SD^a^ (nm)Mean diameter of particles added to nasal lavage proteins ± SD (nm)Relative size increaseMean diameter of particles added to SLPI (nm)Relative size increaseF~WF~130 ± 6230 ± 221.7N/A UF~WF~99 ± 4140 ± 51.5420 ± 94.3Fe~2~O~3~100 ± 3260 ± 262.6330 ± 193.3Fe~3~O~4~26 ± 2160 ± 156.3N/A [^2]

Protein corona formation {#s0022}
------------------------

Significant changes in the diameter of the particles were detected after incubation of the particles with nasal lavage proteins ([Table 1](#t0001){ref-type="table"} and Figure S3). The experiment showed that the protein-driven particle aggregation is time dependent and reproducible data were only obtained by following a strictly time-controlled experimental procedure. The DLS measurement was performed directly following the sonication of the particles. All incubations with particles and nasal lavage proteins were performed within 20 min after the end of particle sonication, which is the time frame in which the particle agglomerates were shown to have a stable size distribution, followed by an additional DLS measurement. Large increases in size following incubation in nasal lavage protein solution were detected for all particles ([Table 1](#t0001){ref-type="table"}). The relative increase in size differed between particle types. For example, Fe~2~O~3~ and UF~WF~ particles were of equal size in suspension, but the diameters increased by a factor of 2.6 and 1.5, respectively, after incubation in nasal lavage protein solution. The amount of bound proteins per particle mass unit also differed between particles (Table S2). Plotting the relative increase in aggregate size versus the amount of bound protein per particle mass unit showed that these two parameters are correlated (Figure S7).

Identification of proteins in the corona {#s0023}
----------------------------------------

Three different concentrations of each particle suspended in water were incubated with nasal lavage proteins ([Scheme 1](#F0001){ref-type="fig"}). Proteins bound to the particles (the protein corona) were identified and relatively quantified by 2DE/MALDI-TOF MS and with targeted LC-MS/MS in selected reaction monitoring (SRM) mode.

Representative 2DE separations of the proteins in the corona showed similar protein patterns for F~WF~, UF~WF~, and Fe~2~O~3~ ([Figure 2](#F0002){ref-type="fig"}, Figure S8, and Table S3). Proteins that bound to these particles to a high degree were lysozyme C and palate lung and nasal epithelium clone (PLUNC). These proteins bound to a lower extent to Fe~3~O~4~. This particle showed an overall different protein composition in its corona, for example, lipocalin 1 was identified in the corona of the Fe~3~O~4~ particles but not in the coronas of any of the other particles. Figure 2.Comparison of protein-corona patterns from different particle, 50 μg of the bound proteins were separated on 2DE. (A) F~WF~, (B) UF~WF~, (C) Fe~2~O~3~, and (D) Fe~3~O~4~. (1) PLUNC, (16) lysozyme C, (7) keratine and (2) lipocalin 1. Each sample was analyzed in triplicates. The most representative gels are presented here. Numbers refer to identified proteins listed in Table S3.

The protein coronas were further analyzed with a complementary method using a label-free targeted LC-MS/MS (Mörtstedt et al., [@CIT0025]). To estimate the degree of binding of each individual protein in the nasal lavage protein solution to the different particle types, a ratio was determined between bound and unbound proteins (*R* ~b/u~). In a first step, the *R* ~b/u~ was calculated for particle concentrations of 400 µg/mL. Proteins with a *R* ~b/u~ ≥ 1 are listed in Table S4 along with the calculated isoelectric point (pI) and molecular weight (kDa) for each protein.

The protein coronas of F~WF~ and UF~WF~ were quite similar (Table S4), but a few proteins were only found bound to one or the other particle. The *R* ~b/u~ ratios for F~WF~ and UF~WF~ were similar indicating that individual proteins bound to the particles with a similar affinity. Fe~2~O~3~ particles bound to the same set of proteins as F~WF~ and UF~WF~. In addition, about 14 unique proteins were observed to bind only to Fe~2~O~3~. The protein corona of the smallest particles, Fe~3~O~4~, was distinct from the coronas of the three other particles. However, the protein coronas formed on the four particles cannot be categorized based on a distinct size, net charge, or hydrophobicity of proteins. The protein binding did not correlate to protein abundance for any of the four particles suggesting that the affinity between protein and particle is important.

Proteins binding with high affinity to the particles {#s0024}
----------------------------------------------------

In order to determine which proteins occupy the particle surface with a high probability, proteins with a high affinity to the particle surface were identified using *R* ~b/u~ ratios. Proteins with *R* ~b/u~ ≥ 1 were considered to be proteins with high affinity for binding to the particle surface, and these were included for further analysis (Table S4). The *R* ~b/u~ at 400 µg/mL ranged from 1 to 1000 suggesting that the affinity of the proteins for the particles differed by a magnitude of approximately 10^3^. The *R* ~b/u~ was also determined for each protein and particle at two lower particle concentrations of 200 µg/mL and 100 µg/mL. At lower particle concentrations, less surface area is available for binding, and this leads to increased competition between binding proteins. It was then possible to compare affinities between the binding proteins. Proteins with significantly decreasing ratios (tested with the Jonckheere--Terpasta statistical test) at particle concentrations lower than at 400 µg/mL were excluded (including proteins at 100 µg/mL and 200 µg/mL with *R* ~b/u~ ≥ 1) because these proteins were considered to have a low affinity for the particles. The remaining proteins are listed in [Table 2](#t0002){ref-type="table"}. These are considered to bind the particles with high affinity and are probably the most interesting proteins in a realistic exposure situation. Table 2.Proteins with high affinity for the particles.  *R*~b/u~AccessionProteinF~WF~UF~WF~Fe~2~O~3~Fe~3~O~4~P06702Protein S100-A91 1 P13647Keratin, type II cytoskeletal 5117 P80511Protein S100-A121   Q96DA0Zymogen granule protein 16 homolog B1   P61626Lysozyme C25  Q7Z3Y7Keratin, type I cytoskeletal 28311 P59827BPI fold-containing family B member 44 730Q96HC4PDZ and LIM domain protein 58 1 P02533Keratin, type I cytoskeletal 1491522 P04406Glyceraldehyde-3-phosphate dehydrogenase14141288Q9NP55BPI fold-containing family A member 11965 P02788Lactotransferrin28811 Q96P63Serpin B12299418612 Q8TDL5BPI fold-containing family B member 136910 P62805Histone H4672345115786Q7Z5L0Vitelline membrane outer layer protein 1 homolog   24P23528Cofilin-1   1Q01469Fatty acid-binding protein, epidermal   1P61769Beta-2-microglobulin   2P04080Cystatin-B   3P13645Keratin, type I cytoskeletal 10   3P04220Ig mu heavy chain disease protein   4P26038Moesin   5P04792Heat shock protein beta-1  714Q08380Galectin-3-binding protein 3 21P60174Triosephosphateisomerase   24P06396Gelsolin   35Q13938Calcyphosin   98P06733Alpha-enolase  8300Q16378Proline-rich protein 4  233P01042Kininogen-1   51Q6UWW0Lipocalin-15   88Q9H293Interleukin-25  1 Q9H299SH3 domain-binding glutamic acid-rich-like protein 3  1 P00558Phosphoglycerate kinase 1  9 P08246Neutrophil elastase  10 P03973Antileukoproteinase 2816 Q9UKX2Myosin-2 1  Q06830Peroxiredoxin-1 1  P49913Cathelicidin antimicrobial peptide 1  P05109Protein S100-A8 7  P02538Keratin, type II cytoskeletal 6A 30  [^3]

For some of the proteins in the corona, the *R* ~b/u~ values were high indicating that a large fraction of the protein was bound to the particle and thus leaving only a small fraction unbound. If the binding affects the function of the protein this might have clinically relevant implications.

Network protein analysis by IPA of the high-affinity proteins for F~WF~ and Fe~2~O~3~ in [Table 2](#t0002){ref-type="table"} shows common connections for nuclear factor kappa beta (NFκB) and tumor necrosis factor alpha (TNF-α), while inerleukin-6 (IL-6) showed a connection for UF~WF~ (Figures S9--S11). This indicates that such binding can influence an inflammatory process. No such connections were found for Fe~3~O~4~ (Figure S12).

Effect of particle--protein interaction on protein functionality {#s0025}
----------------------------------------------------------------

SLPI bound to UF~WF~ and Fe~2~O~3~ particles at an *R* ~b/u~ between 16 and 28 ([Table 2](#t0002){ref-type="table"}) but bound only weakly to F~WF~ and Fe~3~O~4~. This protein was selected for a functionality testing due to the high abundancy in the nasal lavage and high ratio bound to the particles. Before the experiment, the size of the SLPI:particle aggregates was determined ([Table 1](#t0001){ref-type="table"}). The diameter of the formed aggregates was large but could only be determined for UF~WF~ and Fe~2~O~3~. No reproducible results could be obtained for the other particle types.

The potential effect on SLPI function due to the particle binding was tested by measuring the protease activity of HNE on elastine using a fluorogenic substrate (instead of elastine) that gives a fluorescent signal when cleaved (Figure S13A). HNE activity is inhibited by SLPI, (Figure S13B), and we found that increasing concentrations of SLPI alone correlated with a decreasing fluorescent signal demonstrating inhibition of HNE ([Figure 3A](#F0003){ref-type="fig"}). The addition of particles without SLPI had no effect on the HNE activity (data not shown). Low concentrations of SLPI:UF~WF~ and SLPI:Fe~2~O~3~ aggregates eliminated the inhibitory effect of SLPI ([Figure 3A](#F0003){ref-type="fig"} and Figure S13C), and this indicated that SLPI function was lost upon binding to the UF~WF~ and Fe~2~O~3~ particles. At high concentrations of these aggregates, the inhibitory effect was equal to that of SLPI alone, and this was probably due to maximum inhibition being reached. The SLPI:F~WF~ aggregates showed the opposite effect, however, and inhibition of HNE by SLPI was actually increased in these particles. The decreased signal can be explained either by SLPI binding to F~WF~ particles in a way that improves the protein\'s function or by steric hindrance for the substrate to reach to HNE due to large SLPI:F~WF~ aggregates. Figure 3.HNE substrate inhibition. Detection of SLPI inhibition of HNE activity was performed with (A) free SLPI compared with SLPI:F~WF~, SLPI:UF~WF~, and SLPI:Fe~2~O~3~ protein corona complexes and (B) nasal lavage protein (NL, which contains endogenous SLPI) compared with NL:F~WF~, NL:UF~WF~, and NL:Fe~2~O~3~ protein corona complexes.

We next measured the endogenous SLPI inhibition of HNE in the nasal lavage protein background containing endogenous SLPI ([Figure 3B](#F0003){ref-type="fig"}). No inhibition of HNE was observed in nasal lavage protein alone indicating that SLPI primarily inhibits free endogenous HNE present in nasal lavage protein solution or that the effect of SLPI on HNE is delayed due to the presence of other nasal lavage protein proteins. Therefore, no particle effect was expected, and this was the case for F~WF~ and especially for Fe~2~O~3~ because it binds to endogenous HNE (P08246, [Table 2](#t0002){ref-type="table"}). However, adding UF~WF~ particles to nasal lavage decreased the HNE activity. It is possible that differences in the protein corona formation influenced the function of bound SLPI. Thus, it is difficult to predict the influence of protein function induced by particle binding, but changes in activity are clearly possible and are likely to be dependent on particle type.

Discussion {#s0026}
==========

The characteristics of the agglomerates depend on the welding process temperature and on the vapor pressure of the elements. Therefore, the particles were collected as two fractions, F~WF~ and UF~WF~, according to the aerodynamic size of the particles.

DLS is sensitive to larger particles since the intensity of the scattered light is proportional to the sixth power of the particle diameter. It has a low peak resolution, and particles can only be resolved if the size differs by a factor of 3. This makes it difficult to measure an exact size of the agglomerates. But it is fast, easy to operate, and delivers a large amount of statistical data. The shape and the structure of the agglomerates were confirmed with TEM.

Measurement of the formation of the protein corona revealed that although the hydrodynamic particle mean size was similar for Fe~2~O~3~ and UF~WF~ particles, Fe~2~O~3~ bound twice the amount of proteins than the UF~WF~ particles. Thus the chemical composition of the primary particle along with the primary particle size of the agglomerates might determine the specific surface area available for binding (surface area per mass unit).

Both 2DE-MALDI-TOF MS and targeted LC-MS/MS revealed distinct differences in the protein coronas between Fe~3~O~4~ and the other particles. But conflicting results were obtained regarding, for example, lactotransferrin. Targeted analysis showed that three of the particles bound this protein to a high degree, but the 2DE separation and MALDI-TOF MS analysis did not confirm this finding. Prolactin-inducible protein was detected by the 2DE method but not with SRM. Discrepancies between proteins identified by the two methods might arise from a number of methodological differences, e.g. that targeted peptides must be unique for the identified protein or that parameters such as hydrophobicity and abundance might affect the results of 2DE. Furthermore, digestion by trypsin could be sterically inhibited when the protein is bound to the particle. This emphasizes the importance of combining methods.

In a real exposure scenario, many factors, such as particle number concentration, the deposited surface area, and the amount and composition of nasal lavage proteins, might influence the formation of the protein corona. The formation of the protein corona is a dynamic process, and it is possible that in the upper airways the protein corona is constantly being partly or completely changed. There will be a continuous secretion and removal of nasal fluids and deposited particles, and it is possible that the nasal fluid composition can change in response to particle deposition (Albanese et al., [@CIT0001]). These factors, together with the time it will take for equilibrium between proteins and particle surface to be reached (Dell\'orco et al., [@CIT0011]; Lundqvist et al., [@CIT0011]; Tenzer et al., [@CIT0032]), suggest the possibility that there are many different protein coronas present around particles in the nasal fluid at any given time. Furthermore, in the *in vitro* situation, the ratio of particles and proteins will be important. A large number of particles, i.e., a large surface area, in diluted protein samples, will enable proteins with low affinity to the particles to interact due to the excess of particle surface area (Dell\'orco et al., [@CIT0011]). This might lead to the identification of proteins in the corona that would never occur in a real-life scenario where the surface areas are likely to be limited. In this study, we have identified proteins binding with a high affinity to the particles. These proteins were selected due to an increased probability that they remain in the corona for a long time and thus have an increased probability of either influencing the distribution route of the particle or being subjected to inherent functionality changes.

There were still differences between the overall protein coronas in terms of which high-affinity binding proteins were associated with the different particle types ([Table 2](#t0002){ref-type="table"}). The protein corona of Fe~3~O~4~ was distinct compared with the three other particles, and this suggests that the composition of the protein corona depends on particle size and/or chemical composition.

A loss of inhibitory function of SLPI was observed when the protein was incubated with UF~WF~ and Fe~2~O~3~ particles in an HNE activity assay. The F~WF~ particles, however, appeared actually to not cause any loss of the inhibitory function of SLPI. Thus, it is difficult to predict the potential influence that particle binding has on protein functionality, but this is still a relevant factor to investigate. The majority of the amount of SLPI in nasal lavage was shown to bind to UF~WF~ and Fe~2~O~3~ particles leaving little unbound SLPI left. Thus, any functional alteration would have a significant impact on the overall mechanism. In general, binding of proteins to nanoparticles may be an important mechanism underlying a toxicological response due to any functional alteration induced during the particle-protein interaction.

Most of the proteins presented in [Table 2](#t0002){ref-type="table"} are associated with acute phase responses and immunological responses, and differences in the protein corona might have implications for the biological response caused by the particles. The somewhat different coronas identified for different particles suggest that the initiation of different biological pathways could be expected upon inhalation of the particles. Example of proteins with potential interest is BPI fold-containing family B member 4, which was found to bind to a much higher degree to Fe~3~O~4~ than to the F~WF~ and Fe~2~O~3~ particles. This protein has a lipid binding capacity, and it also acts as an odorant carrier through the mucus to receptor sites. Lipocalin-15, a transport protein that enables direct movement of substances into the cell, was found to bind almost exclusively to Fe~3~O~4~ particles. Previous studies have shown cellular uptake of nanoparticles through endocytosis (Albanese et al., [@CIT0001]; Chen et al., [@CIT0010]), and it might be possible that nanoparticles with strong affinity for these proteins will be taken up by cells more efficiently. However, this hypothesis needs to be further evaluated, for example, by exposing cells to particles coated with these proteins.

Conclusions {#s0027}
===========

In this study, particles were collected from welding fumes and compared with model particles with a well-defined size distribution and less chemical complexity. Analyses of the protein corona formation and the identification of the protein corona formed between different particle types and nasal lavage proteins were performed. The results showed that chemical composition, physical shape, and agglomeration state of the particle influenced particle--protein interactions and functionality of bound proteins. In addition, the protein pattern of the corona differed between the particle types. Thus, it is important to include particles from real working environments and not just study more homogenous model particles.

In summary we demonstrate thatThe amount of protein bound to each particle type correlate with the relative size increase of the aggregates, suggesting that the surface area per mass unit determines the binding capacity.The relative increase in aggregate size following addition of nasal lavage proteins to particles showed that the increase was not only associated with particle size.The overall nasal lavage protein corona differed between particle types.The Fe~3~O~4~ particles, composed of the smallest agglomerates, had a very specific protein corona.The protein corona that formed did not correlate with the abundance of the proteins or with their size or net charge.Subsets of proteins were identified as binding with high affinity to different particles. These proteins should be investigated in further studies because they might have relevant associations with toxicological responses.When proteins bind to particles, the function of the protein can be influenced in different ways as shown by SLPI in this study. The inhibitory function of SLPI was decreased when bound to UF~WF~ and Fe~2~O~3~ particles, but not when bound to F~WF~ particles.
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[^2]: Analysis was performed with dynamic light scattering.

    ^a^Standard deviations based on three measurements. Measurements were performed over prolonged incubation times to determine the stability of the agglomerates. No changes were observed in 20 min.

    N/A: No significant reproducible results could be obtained.

[^3]: These include proteins that bind to the particles with *R* ~b/u~ ≥ 1 and for which the *R* ~b/u~ are stable in decreasing particle concentration. The *R* ~b/u~ values shown here represent the protein binding ratio with a 100 µg/mL particle concentration.
